|
|
Article: Transferrin as a Targeting Ligand for Liposomes and Anticancer Drugs.
- Article from:
- Gene Therapy Weekly
- Article date:
- August 16, 1999
CopyrightCOPYRIGHT 1999 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Drug Delivery
Singh, M. "Transferrin as a Targeting Ligand for Liposomes and Anticancer Drugs." Current Pharmaceutical Design, June 1999;5(6):443-451.
(CW HENDERSON PUBLISHER www.newsfile.com) -- According to the author's abstract of an article published in Current Pharmaceutical Design, "In cancer treatment, one of the approaches is targeting of the drug to tumor cells via receptor specific ligands. Transferrin (molecular weight 80,000) has been used as a ligand for delivering anticancer drugs or drug-containing liposomes mostly due to the increased number of transferrin (trf) receptors found on tumor cells as compared to normal cells. Transferrin was ...